Ngā hua rapu - Nigel Temperton

Whakamahine hua
  1. 1
    Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis

    Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis mā Francesca Ferrara, Nigel Temperton

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    An optimised method for the production of MERS-CoV spike expressing viral pseudotypes

    An optimised method for the production of MERS-CoV spike expressing viral pseudotypes mā Keith Grehan, Francesca Ferrara, Nigel Temperton

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Distinct Mitochondrial and Cytosolic Enzymes Mediate Trypanothione-dependent Peroxide Metabolism in Trypanosoma cruzi

    Distinct Mitochondrial and Cytosolic Enzymes Mediate Trypanothione-dependent Peroxide Metabolism in Trypanosoma cruzi mā Shane R. Wilkinson, Nigel Temperton, Angeles Mondragon, John M. Kelly

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry

    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry mā Jason S. Long, Edward Wright, Eleonora Molesti, Nigel Temperton, William Barclay

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis

    Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis mā George Carnell, Francesca Ferrara, Keith Grehan, Craig Thompson, Nigel Temperton

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry

    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry mā Jason S. Long, Edward Wright, Eleonora Molesti, Nigel Temperton, William Barclay

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Pré-impressão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility

    Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may... mā Holly Shelton, Kim L. Roberts, Eleonora Molesti, Nigel Temperton, William Barclay

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future

    Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future mā Claudia Maria Trombetta, Daniele Perini, Stuart Mather, Nigel Temperton, Emanuele Montomoli

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods

    Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods mā Anto Vrdoljak, Evin A. Allen, Francesca Ferrara, Nigel Temperton, Abina M. Crean, Anne Moore

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes

    Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes mā Nigel Temperton, Paul K.S. Chan, Graham Simmons, Maria Zambon, Richard S. Tedder, Yasuhiro Takeuchi, Robin A. Weiss

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays

    Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays mā Inesa Hyseni, Eleonora Molesti, Linda Benincasa, Pietro Piu, Elisa Casa, Nigel Temperton, Alessandro Manenti, Emanuele Montomoli

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison

    Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison mā Edward Wright, Nigel Temperton, Denise A. Marston, Lorraine M. McElhinney, Anthony R. Fooks, Robin A. Weiss

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses <i>In Vitro</i>

    Chicken Interferon-Inducible Transmembrane Protein 3 Restricts Influenza Viruses and Lyssaviruses <i>In Vitro</i> mā Sarah E. Smith, Mark S. Gibson, R. Wash, Francesca Ferrara, Edward Wright, Nigel Temperton, Paul Kellam, Mark Fife

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Antigenic Drift in H5N1 Avian Influenza Virus in Poultry Is Driven by Mutations in Major Antigenic Sites of the Hemagglutinin Molecule Analogous to Those for Human Influenza Virus

    Antigenic Drift in H5N1 Avian Influenza Virus in Poultry Is Driven by Mutations in Major Antigenic Sites of the Hemagglutinin Molecule Analogous to Those for Human Influenza Virus mā Giovanni Cattoli, Adelaide Milani, Nigel Temperton, Bianca Zecchin, Alessandra Buratin, Eleonora Molesti, Mona Meherez Aly, Abdel-Satar Arafa, Ilaria Capua

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor

    Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor mā Efstathios S. Giotis, George Carnell, Erik F. Young, Saleena Ghanny, Patricia Soteropoulos, Lin‐Fa Wang, William Barclay, Michael A. Skinner, Nigel Temperton

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Adjuvant-Free Immunization with Hemagglutinin-Fc Fusion Proteins as an Approach to Influenza Vaccines

    Adjuvant-Free Immunization with Hemagglutinin-Fc Fusion Proteins as an Approach to Influenza Vaccines mā Silvia Loureiro, Junyuan Ren, Pongsathon Phapugrangkul, Camilo Colaço, Christopher R. Bailey, Holly Shelton, Eleonora Molesti, Nigel Temperton, William Barclay, Ian M. Jones

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Stalking influenza by vaccination with pre-fusion headless HA mini-stem

    Stalking influenza by vaccination with pre-fusion headless HA mini-stem mā Sophie A. Valkenburg, Vamsee Mallajosyula, Olive T. W. Li, Alex W. H. Chin, George Carnell, Nigel Temperton, Raghavan Varadarajan, Leo L. M. Poon

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

    Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection mā Lorena Itatí Ibañez, Marina De Filette, Anna Hultberg, Theo Verrips, Nigel Temperton, Robin A. Weiss, Wesley Vandevelde, Bert Schepens, Peter Vanlandschoot, Xavier Saelens

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses

    Virus neutralising activity of African fruit bat (Eidolon helvum) sera against emerging lyssaviruses mā Edward Wright, David T. S. Hayman, Aisling Vaughan, Nigel Temperton, James L. N. Wood, Andrew A. Cunningham, Richard Suu‐Ire, Robin A. Weiss, Anthony R. Fooks

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection

    Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection mā Vamsee Mallajosyula, Michael Citron, Francesca Ferrara, Xianghan Lu, Cheryl Callahan, Gwendolyn J. Heidecker, Siddhartha P. Sarma, Jessica A. Flynn, Nigel Temperton, Xiaoping Liang, Raghavan Varadarajan

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: